Search

everythinglearnresearchcommunity

for

Search:↓

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

No cure exists for alopecia areata, and treatments are personalized.

Alopecia areata involves specific immune cells, offering potential treatment targets.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

Trichoscopy is essential for diagnosing and treating autoimmune cicatricial alopecia early.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Children with alopecia areata often have related health issues like allergies, autoimmune diseases, or mental health conditions.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.